Subscribe To

Price Alert Latest News Economic Calendar News

CYRX / Cryoport shares slide 29% after revenue warning

Shares of Cryoport Inc. CYRX, +3.58% fell 29% in premarket trading on Thursday after the life-science logistics company issued a revenue warning, noting weaker than expected global demand for capital equipment and clinical trial start delays. Cryoport expects second quarter revenue to be in the range of $56.5 million to $57.5 million, down 11% at the midpoint from the same period a year earlier, the company said in a release late Wednesday. Read More

Demo Live Account See Partner Details

Content Topics

Cryoport

Slide

After

Revenue

Warning

Stock

CYRX

Posted: Jul 13 2023, 08:07

Author Name: Market Watch

CYRX News

By Seeking Alpha
July 14, 2023

Cryoport: Revising To Hold After Major Changes To Forecasts, Sentiment

Cryoport released preliminary Q2 results, projecting sales to fall behind The Street's estimates. Lower demand for Cryoport's capital equipment and de

By The Motley Fool
July 13, 2023

Why Shares of Cryoport are Tumbling Thursday

Cryoport downgraded annual guidance. The company has seen a slowdown in orders from gene therapy and cell therapy clients.

By InvestorPlace
July 13, 2023

Why Is CryoPort (CYRX) Stock Down 26% Today?

CryoPort (NASDAQ: CYRX ) stock is falling on Thursday after the cell and gene therapy products company released preliminary results for the second qua

By Market Watch
July 13, 2023

Cryoport shares slide 29% after revenue warning

Shares of Cryoport Inc. CYRX, +3.58% fell 29% in premarket trading on Thursday after the life-science logistics company issued a revenue warning, noti

By Seeking Alpha
July 4, 2023

Cryoport: A Strong Player In Cold-Chain Logistics With Solid Growth Prospects

Cryoport, Inc. is well-positioned to benefit from the growth in the cell and gene therapy industry due to its dominant position in the cold-chain logi

By Seeking Alpha
May 5, 2023

Cryoport, Inc. (CYRX) Q1 2023 Earnings Call Transcript

Cryoport, Inc. (NASDAQ:CYRX ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Todd Fromer - Investor Relations Jerrell Sh

By Seeking Alpha
February 23, 2023

Cryoport, Inc. (CYRX) Q4 2022 Earnings Call Transcript

Cryoport, Inc. (NASDAQ:CYRX ) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants Todd Fromer - Managing Partner-KCSA J

By Seeking Alpha
February 8, 2023

Cryoport: Differentiated Offering In The Life Sciences Value Chain

Cryoport has been punished over the last 12 months amid a number of downside catalysts. Shares have recently curled up off 52-week lows, asking the qu

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.